Suicide rates in short-term randomized controlled trials of newer antidepressants

Journal of Clinical Psychopharmacology

Volumn 26, Issue 2, 2006, Pages 203-207

  Hammad, Tarek A ^a   Laughren, Thomas P ^a   Racoosin, Judith A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; DEPRESSION; HUMAN; MAJOR DEPRESSION; NORTH AMERICA; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SUICIDE;

EID: 33646700743     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000203198.11453.95     Document Type: Article

References (12)

1. Black DW, Warrack G, Winokur G. Excess mortality among psychiatric patients: the Iowa Record-Linkage study. JAMA. 1985;253:58-61.
2. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry. 1991;36:239-254.
3. Michels KB, Rothman KJ. Update on unethical use of placebos in randomized trials. Bioethics. 2003;17(2):188-204.
4. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Arch Gen Psychiatry. 2000;57:311-317.
5. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990;147:207-210.
6. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63:332-339.
7. Storosum JG, van Zweiten BJ, van den Brink W, et al. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry. 2001;158:1271-1275.
8. Beasley CM Jr, Dornseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ. 1991;303:685-692.
9. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA's safety review. BMJ. 2005;330:385-390.
10. Ferguson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ. 2005;330:396-403.
11. Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case control study. BMJ. 2005;330:389-395.
12. Jick H, Kaye JA, Jick S. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292:338-343.